Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐Trypanosoma cruzi and Anti‐Leishmania mexicana Agents

Documenti analoghi

• Ligand‐Based Pharmacophore Modeling and Structure‐Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS‐CoV‐2 Spike Protein‐ACE2 Receptor Interaction
  di: Timoteo Delgado‐Maldonado, et al.
  Pubblicazione: (2026)
• Sustainable Modification of Minimolide: Influence of Structure and Acylation Pattern on Anti‐ Trypanosoma cruzi Activity
  di: Orlando G. Elso, et al.
  Pubblicazione: (2025)
• Selenocyanate‐Containing Molecules as Trypanosoma cruzi Inhibitors: Impact of Regioisomerism, Conformational Restriction, and Second‐Ring Substitution
  di: Hugo S. Steingrüber, et al.
  Pubblicazione: (2025)
• Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids with Cytotoxic and Anti‐Inflammatory Effects
  di: Luis Roberto Garduño‐Villavicencio, et al.
  Pubblicazione: (2024)
• Structure‐Metabolism Relationships of Benzimidazole Derivatives with anti‐Trypanosoma cruzi Activity for Chagas Disease
  di: Rocío Marisol Espinoza‐Chávez, et al.
  Pubblicazione: (2024)